TCG Crossover Management as of Sept. 30, 2024
Portfolio Holdings for TCG Crossover Management
TCG Crossover Management holds 36 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology Comm (CGON) | 11.7 | $139M | 3.7M | 37.73 | |
| Dyne Therapeutics Comm (DYN) | 8.1 | $95M | 2.7M | 35.92 | |
| Cogent Biosciences Comm (COGT) | 6.4 | $75M | 7.0M | 10.80 | |
| Abivax SA Adrs (ABVX) | 5.9 | $70M | 6.1M | 11.52 | |
| Edgewise Therapeutics Comm (EWTX) | 4.8 | $56M | 2.1M | 26.69 | |
| Silence Therapeutics Adrs (SLN) | 4.7 | $55M | 3.0M | 18.18 | |
| Savara Comm (SVRA) | 4.4 | $52M | 12M | 4.24 | |
| Keros Therapeutics Comm (KROS) | 4.3 | $51M | 879k | 58.07 | |
| Xencor Comm (XNCR) | 4.1 | $49M | 2.4M | 20.11 | |
| Tyra Biosciences Comm (TYRA) | 4.0 | $47M | 2.0M | 23.51 | |
| Structure Therapeutics Adrs (GPCR) | 4.0 | $47M | 1.1M | 43.89 | |
| Ocular Therapeutix Comm (OCUL) | 3.9 | $46M | 5.3M | 8.70 | |
| Centessa Pharmaceuticals Comm | 3.9 | $46M | 2.9M | 15.99 | |
| Tourmaline Bio Comm (TRML) | 3.2 | $38M | 1.5M | 25.71 | |
| Third Harmonic Bio Comm (THRD) | 2.8 | $33M | 2.4M | 13.55 | |
| Astria Therapeutics Comm | 2.6 | $30M | 2.8M | 11.01 | |
| Mineralys Therapeutics Comm (MLYS) | 2.5 | $30M | 2.5M | 12.11 | |
| Kura Oncology Comm (KURA) | 2.4 | $28M | 1.4M | 19.54 | |
| Soleno Therapeutivs Comm | 2.4 | $28M | 550k | 50.49 | |
| Compass Pathways Adrs (CMPS) | 2.1 | $24M | 3.9M | 6.30 | |
| Disc Medicine Comm (IRON) | 2.0 | $24M | 487k | 49.14 | |
| Fulcrum Therapeutics Comm (FULC) | 1.6 | $19M | 5.3M | 3.57 | |
| Mbx Biosciences Comm (MBX) | 1.4 | $17M | 650k | 25.98 | |
| Amylyx Pharmaceuticals Comm (AMLX) | 1.3 | $15M | 4.6M | 3.24 | |
| Adverum Biotechnologies Comm (ADVM) | 1.2 | $14M | 2.0M | 7.02 | |
| Entrada Therapeutics Comm (TRDA) | 0.8 | $9.3M | 585k | 15.98 | |
| Vistagen Therapeutics Comm (VTGN) | 0.7 | $8.1M | 2.7M | 3.01 | |
| Tarsus Pharmaceuticals Comm (TARS) | 0.6 | $7.6M | 232k | 32.89 | |
| EyePoint Pharmaceuticals Comm (EYPT) | 0.6 | $7.4M | 922k | 7.99 | |
| Nektar Therapeutics Comm | 0.4 | $5.2M | 4.0M | 1.30 | |
| Aerovate Therapeutics Comm (AVTE) | 0.4 | $4.7M | 2.2M | 2.09 | |
| Avalo Therapeutics Comm (AVTX) | 0.4 | $4.6M | 483k | 9.50 | |
| Kodiak Sciences Comm (KOD) | 0.2 | $2.6M | 1.0M | 2.61 | |
| AN2 Therapeutics Comm (ANTX) | 0.1 | $1.7M | 1.6M | 1.07 | |
| Ventyx Biosciences Comm (VTYX) | 0.1 | $689k | 316k | 2.18 | |
| Cabaletta Bio Comm (CABA) | 0.0 | $410k | 87k | 4.72 |
